MARKET NEWS

TYME Presents Positive Circulating Tumor Cell Data
Kitov Pharma Presents Newly Released Data for Reversing Pancreatic Cancer Drug Resistance
Toronto Innovation Acceleration Partners Announces Strategic Partnership With Amgen
ORYZON’s Ladademstat Shows Efficacy Signs in Relapsed SCLC
ProBioGen Licenses Technology to Bayer
Flexion Therapeutics & Xenon Pharmaceuticals Announce Acquisition

  FEATURED EDITORIAL

  COMPANY PROFILE


For nearly 30 years, DDL has provided extraordinary service and specialized testing expertise to the medical device and pharmaceutical industries. Our reliable quality, responsive attention, and on-schedule completion for packaging, medical device, and combination products testing secures confidence in performance and safety while achieving regulatory compliance. Click here for more.

  EXCLUSIVE ONLINE CONTENT

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

This e-Book showcases the various types of services that leading testing companies offer and how they are helping industry comply with regulations to get their products approved and commercialized.

DURECT Earns -Million Milestone Payment From Gilead

DURECT Earns $10-Million Milestone Payment From Gilead

DURECT Corporation recently announced that further development of a long-acting injectable HIV investigational product utilizing DURECT’s SABER technology has triggered a $10-million milestone payment from Gilead Sciences, Inc. to…….

Pfenex Earns -Million Development Milestone

Pfenex Earns $11-Million Development Milestone

Pfenex Inc. recently announced it has earned an $11-million development milestone under its development and license agreement with Jazz Pharmaceuticals. The milestone is associated with…….

FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement for Biotherapeutic Development

FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement for Biotherapeutic Development

The new formula has been developed to increase galactosylation in biotherapeutic development, to help achieve….

Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center

Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center

Kaleido Biosciences, Inc. recently announced plans to develop Microbiome Metabolic Therapies (MMT) to enhance the effects of cancer immunotherapies under a new…….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 25 – Excipients
October 2 – Gene Therapy